Skip to main content

Table 4 Factors associated with purchasing an RDT in the ADDO when the patient was present

From: Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment

Outcome: receiving an RDT in an ADDO if present to be tested (n = 464)

Bivariable

Multivariable

OR

95% CI

p value

OR

95% CI

p value

Intervention

 No subsidy

Reference

   

 Subsidy

1.1

(0.6–1.9)

0.868

   

Customer gender (if not patient)

 Female

Reference

   

 Male

1.2

(0.5–2.7)

0.654

   

Patient gender

 Female

Reference

   

 Male

1.0

(0.7–1.4)

0.920

   

Customer age (if not patient)

1.0

(1.0–1.0)

0.198

   

Patient age

 <5 years

Reference

   

 5− <14 years

1.5

(0.7–3.5)

0.332

   

 14+ years

0.7

(0.3–1.3)

0.254

   

Customer education

 Primary

Reference

   

 Secondary and above

1.0

(0.6–1.6)

0.909

   

Wealth index

 Lowest

Reference

   

 Lower

1.0

(0.5–2.0)

0.925

   

 Middle

0.9

(0.4–1.8)

0.723

   

 Higher

1.2

(0.6–2.5)

0.559

   

 Highest

1.0

(0.5–2.2)

0.943

   

Has heard of RDTs

3.1

(2.0–4.8)

<0.001

1.7

(0.9–3.1)

0.088

Has taken an RDT before

3.1

(2.1–4.7)

<0.001

1.9

(1.2–3.0)

0.005

Sought treatment prior to ADDO visit

0.3

(0.2–0.5)

<0.001

0.3

(0.2–0.5)

<0.001

Knew before coming that testing was available in ADDOs

3.0

(2.0–4.7)

<0.001

1.9

(1.1–3.3)

0.032

Believes febrile patients should be blood tested before treating

 

 Never

Reference

   

 Sometimes

1.1

(0.1–8.9)

0.925

   

 Always

2.0

(0.3–13.9)

0.474